Our tracer incorporates FAP within a dual-target construct; consistent with these findings, we observed significantly higher pulmonary SUVmax in ILD patients than in non-ILD controls, providing real-time evidence of ongoing fibrotic activity across the whole lung in CTD-ILD. This evidence concerns the gene FAP and interstitial lung disease.